Insider · CIK 0001799355

Cadoret-Manier Onaiza

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001799355

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	ARDXARDELYX, INC.A Award	Director	AAward	+26.5K sh	—	—	178,156
2026-06-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+39.7K sh	—	—	39,715
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.9K sh	—	—	0
2026-03-04	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.4K sh	—	—	0
2025-06-18	ARDXARDELYX, INC.A Award	Director	AAward	+41.6K sh	—	—	151,701
2025-06-18	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+54.1K sh	—	—	54,059
2025-06-05	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-06-14	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.2K sh	—	—	40,243
2024-06-06	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33K sh	—	—	33,000
2024-02-02	IONSIONIS PHARMACEUTICALS INCS Sale	EVP,Chf GL Pdt Str & Oper Ofc	SSale	−2,125 sh	$49.60	−$105K	35,825
2024-02-02	IONSIONIS PHARMACEUTICALS INCS Sale	EVP,Chf GL Pdt Str & Oper Ofc	SSale	−2,162 sh	$49.60	−$107K	35,788
2024-02-01	IONSIONIS PHARMACEUTICALS INCA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+4,140 sh	—	—	37,950
2024-01-21	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2024-01-17	IONSIONIS PHARMACEUTICALS INCS Sale	EVP,Chf GL Pdt Str & Oper Ofc	SSale	−5,564 sh	$50.42	−$281K	33,810
2024-01-16	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	+15.1K sh	—	—	39,374
2024-01-16	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	−15.1K sh	—	—	66,997
2024-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+27K sh	—	—	55,635
2024-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+32.4K sh	—	—	82,059
2024-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+43.2K sh	—	—	43,200
2023-06-15	ARDXARDELYX, INC.A Award	Director	AAward	+12.8K sh	—	—	110,150
2023-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+49.2K sh	—	—	49,237
2023-06-15	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.9K sh	—	—	15,937
2023-04-18	IONSIONIS PHARMACEUTICALS INCS Sale	EVP,Chf GL Pdt Str & Oper Ofc	SSale	−2,582 sh	$36.50	−$94.2K	24,312
2023-04-17	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	+5,667 sh	—	—	26,894
2023-04-17	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	−5,667 sh	—	—	49,659
2023-02-06	IONSIONIS PHARMACEUTICALS INCS Sale	EVP,Chf GL Pdt Str & Oper Ofc	SSale	−1,451 sh	$40.66	−$59K	21,227
2023-02-03	IONSIONIS PHARMACEUTICALS INCA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+4,140 sh	—	—	22,678
2023-01-18	IONSIONIS PHARMACEUTICALS INCS Sale	EVP,Chf GL Pdt Str & Oper Ofc	SSale	−3,748 sh	$39.55	−$148K	18,538
2023-01-17	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	+10.2K sh	—	—	22,286
2023-01-17	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	−10.2K sh	—	—	55,326
2023-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+16.2K sh	—	—	28,635
2023-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+19.5K sh	—	—	65,523
2023-01-11	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.4K sh	—	—	20,427
2023-01-11	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.9K sh	—	—	12,880
2023-01-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+25.9K sh	—	—	25,946
2022-06-15	ARDXARDELYX, INC.A Award	Director	AAward	+91.2K sh	—	—	97,395
2022-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-04-18	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	+5,667 sh	—	—	14,049
2022-04-18	IONSIONIS PHARMACEUTICALS INCF Tax Payment	EVP,Chf GL Pdt Str & Oper Ofc	FTax Payment	−1,960 sh	$41.01	−$80.4K	12,089
2022-04-18	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	−5,667 sh	—	—	46,063
2022-01-18	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	+6,057 sh	—	—	10,687
2022-01-18	IONSIONIS PHARMACEUTICALS INCF Tax Payment	EVP,Chf GL Pdt Str & Oper Ofc	FTax Payment	−2,305 sh	$30.12	−$69.4K	8,382
2022-01-18	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP,Chf GL Pdt Str & Oper Ofc	MExercise/Conversion	−6,057 sh	—	—	51,730
2022-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+12.4K sh	—	—	12,419
2022-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+16.6K sh	—	—	57,787
2022-01-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP,Chf GL Pdt Str & Oper Ofc	AAward	+33.1K sh	—	—	33,118
2021-08-31	IONSIONIS PHARMACEUTICALS INCJ Other	EVP,Chf GL Pdt Str & Oper Ofc	JOther	+431 sh	$33.80	+$14.6K	4,630

Recent filings

Accepted (ET)
Jun 184
Cadoret-Manier Onaiza0001799355-26-000006
SEC(opens sec.gov)
Mar 44
Cadoret-Manier Onaiza0001799355-26-000002
SEC(opens sec.gov)
Jun 234
Cadoret-Manier Onaiza0001628280-25-032726
SEC(opens sec.gov)
Jun 64
Cadoret-Manier Onaiza0000950170-25-082978
SEC(opens sec.gov)
Sep 44/A
Cadoret-Manier Onaiza0000874015-24-000194
SEC(opens sec.gov)
Jun 174
Cadoret-Manier Onaiza0001628280-24-028598
SEC(opens sec.gov)
Jun 74
Cadoret-Manier Onaiza0001415889-24-015989
SEC(opens sec.gov)
Feb 24
Cadoret-Manier Onaiza0000874015-24-000104
SEC(opens sec.gov)
Jan 234
Cadoret-Manier Onaiza0001209191-24-002088
SEC(opens sec.gov)
Jan 184
Cadoret-Manier Onaiza0000874015-24-000081
SEC(opens sec.gov)
Jan 174
Cadoret-Manier Onaiza0000874015-24-000052
SEC(opens sec.gov)

Companies

Address

C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210

WALTHAM, MA, 02451